Project description
Reducing stigma and burden for people with mental health conditions
People with mental illness experience stigma, prejudice and discrimination. Often, their families are also targets. To reverse this trend, researchers are studying the associated risks and resilience. The EU-funded R2D2-MH project will propose a double paradigm shift to improve the well-being of people with mental health conditions and their families. By involving patients in the research, the project will start from a risk-focused approach to understand and promote resilience. It will also undertake a diagnosis-based approach and a developmental diversity approach that define well-being and functioning across the human lifespan. R2D2-MH will provide the largest European multiscale data set on early human brain development and mental health outcomes. It will also establish predictive models to guide personalised interventions.
Objective
Individuals with mental health (MH) conditions and their families, especially those with highly prevalent neurodevelopmental disorders (NDDs), are exposed to high levels of discrimination and stigma, which significantly affects their physical and mental well-being. Our world-leading collaborative group at the forefront of research in NDDs will launch a new project - ?Risk, Resilience and Developmental Diversity in Mental Health? (R2D2-MH). We propose a double paradigm shift to improve the wellbeing of people with MH conditions and their families. We will move (i) from risk-focused studies towards understanding and promoting resilience, and (ii) from a diagnosis-based approach to a developmental diversity approach that will define wellbeing and functioning across the human lifespan. R2D2-MH aims to identify genetic and environmental protective/resilience factors and how they influence developmental diversity and MH. We will investigate at multiple levels two highly prevalent early risks for MH conditions: prematurity and genetic liability for NDDs. Our project has four main ambitions 1. Provide the largest European multi-scale dataset on early human brain development and MH outcomes; 2 Identify biological mechanisms of resilience to the adverse effects of NDD; 3. Co-develop, with the stakeholders, new digital tools to increase participatory research/medicine and reduce stigma; 4. Establish predictive models to guide personalised interventions. R2D2-MH integrates interdisciplinary and complementary expertise across Europe, Israel, and Australia that covers ethics, epidemiology, sociology, genetics, cell biology, neuroscience, computational modelling, Information Technology, psychology, and psychiatry. Our research is highly engaged: it embeds participant and patient involvement in research to ensure that our expected outcomes are truly translational, and will help to reduce stigma and burden for individuals with MH conditions.
Fields of science
Keywords
Programme(s)
Funding Scheme
HORIZON-RIA - HORIZON Research and Innovation ActionsCoordinator
75724 Paris
France
See on map
Participants (16)
6525 GA Nijmegen
See on map
D02 CX56 DUBLIN 2
See on map
75015 PARIS 15
See on map
80539 Munchen
See on map
60323 Frankfurt Am Main
See on map
75012 Paris
See on map
84105 Beer Sheva
See on map
8000 Aarhus C
See on map
80333 Munchen
See on map
2000 Antwerpen
See on map
78000 Versailles
See on map
17177 Stockholm
See on map
4592000 KFAR MALAL
See on map
The organization defined itself as SME (small and medium-sized enterprise) at the time the Grant Agreement was signed.
20157 Milano
See on map
7522 NB Enschede
See on map
28003 Madrid
See on map
Partners (10)
Partner organisations contribute to the implementation of the action, but do not sign the Grant Agreement.
4072 Brisbane
See on map
Partner organisations contribute to the implementation of the action, but do not sign the Grant Agreement.
4070 Basel
See on map
Partner organisations contribute to the implementation of the action, but do not sign the Grant Agreement.
3220 Geelong Victoria
See on map
Partner organisations contribute to the implementation of the action, but do not sign the Grant Agreement.
3052 Parkville
See on map
Partner organisations contribute to the implementation of the action, but do not sign the Grant Agreement.
WC2R 2LS London
See on map
Partner organisations contribute to the implementation of the action, but do not sign the Grant Agreement.
CB2 1TN Cambridge
See on map
Partner organisations contribute to the implementation of the action, but do not sign the Grant Agreement.
WC1E 7HX London
See on map
Partner organisations contribute to the implementation of the action, but do not sign the Grant Agreement.
1211 Geneve
See on map
Partner organisations contribute to the implementation of the action, but do not sign the Grant Agreement.
CV4 8UW COVENTRY
See on map
Partner organisations contribute to the implementation of the action, but do not sign the Grant Agreement.
M5G 1X8 Toronto
See on map